Overview

Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the impact of Schistosoma mansoni infection and its treatment on genital immunology and HIV susceptibility in Ugandan women.
Phase:
Phase 4
Details
Lead Sponsor:
University of Toronto
Collaborator:
UVRI-IAVI HIV Vaccine Program, Uganda
Treatments:
Praziquantel